GlassScriptPhysician profile
Amy Lynn Carter
NPI 1316550452
$437.22
in general payments reported to CMS, 2019-2025
13 companies · $51.80 in 2025
The $51.80 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $70.93 · 2022: $297 · 2023: $17.82 · 2025: $51.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $69.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $69.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $70.45 | 2022 | |
| Biotronik INC. | $65.69 | 2022 | |
| Depuy Synthes Sales INC. | $51.80 | 2025 | Trufill |
| Amgen INC. | $38.50 | 2021-2022 | |
| Medtronic, INC. | $35.40 | 2021 | |
| Janssen Pharmaceuticals, INC | $30.60 | 2022 | |
| Boston Scientific Corporation | $25.67 | 2022 | |
| Kestra Medical Technology Services, INC. | $24.46 | 2022 | |
| Heartflow, INC. | $22.09 | 2022 | |
| Arbor Pharmaceuticals, INC. | $21.59 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $17.82 | 2023 | Onivyde, Somatuline Depot |
| Tactile Systems Technology INC | $17.17 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $15.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.